Atossa Highlights Emerging Opportunity for (Z)-Endoxifen in Duchenne Muscular Dystrophy, Including Symptomatic Female Carriers, Following Peer-Reviewed Publication and ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, announces a growing body of scientific ...

AI Startups Sakana, Turing Get Funds as Japan’s Attraction Grows

Japanese self-driving tech startup Turing Inc. said Monday it raised about ¥15.3 billion from investors including Toyota ...